Eckert & Ziegler BEBIG’s mission is to develop and provide innovative medical devices to cure cancer around the world.

Eckert & Ziegler BEBIG is a European-based group active in the medical device segment of the health care industry.

Eckert & Ziegler BEBIG’s core business is the treatment of cancer using brachytherapy, a special form of radiation therapy.

Eckert & Ziegler BEBIG is a leader in brachytherapy in Europe. The company headquarters are in Belgium, with a production facility in Germany and subsidiaries throughout Europe and in India. In addition, Eckert & Ziegler BEBIG has a worldwide network of distributors and agents to support the international marketing of its product line.

The company’s products and equipment are intended for use by oncologists, radiologists, urologists, and medical physicists.

Eckert & Ziegler BEBIG employs more than 150 people. The company has been listed on the Euronext stock exchange since April 1997.

Brachytherapy is a form of radiotherapy that treats cancer by irradiation from a short distance. Two different forms of brachytherapy are used today: permanent and temporary brachytherapy.In permanent brachytherapy, a small radioactive source is implanted in the body, while in temporary brachytherapy, the radioactive source is placed directly inside or close to the site of the tumor for a limited and defined period.

Contributing to saving lives !